L. D. Brown and . Condreay, Identification and characterization of mutations in hepatitis B virus resistant to lamivudine, Hepatology, vol.27, pp.1670-1677, 1998.

R. Colledge, A. Edwards, A. Ayres, S. Bartholomeusz, and . Locarnini, Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase, Gastroenterology, vol.125, pp.292-297, 2003.

C. Villeneuve, F. Trépo, and . Zoulim, Susceptibility to antivirals of an HBV strain with mutations conferring resistance to both lamivudine and adefovir, Hepatology, vol.41, pp.1391-1398, 2005.

E. Dannaoui, C. Trépo, and F. Zoulim, Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription, Antiviral Chemistry and Chemotherapy, vol.21, issue.1, pp.38-46, 1997.
DOI : 10.1177/095632029700800104

W. E. Delaney, H. 4th, C. E. Yang, K. Westland, E. Das et al., The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro, Journal of Virology, vol.77, issue.21, pp.11833-11841, 2003.
DOI : 10.1128/JVI.77.21.11833-11841.2003

F. Trepo and . Zoulim, A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus, Hepatology, vol.40, pp.855-864, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00137151

L. Fu, S. H. Liu, and Y. C. Cheng, Sensitivity of l-(-)2???,3???-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues, Biochemical Pharmacology, vol.57, issue.12, pp.1351-1359, 1999.
DOI : 10.1016/S0006-2952(99)00073-8

J. Wang, A. Delehanty, E. Rigney, A. Mondou, F. Snow et al., Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection, Antimicrob Agents Chemother, vol.46, pp.1734-1740, 2002.

K. A. Staschke and J. M. Colacino, Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine, J Virol, vol.68, pp.8265-8269, 1994.

J. E. Tavis, B. Massey, and Y. Gong, The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon, J Virol, vol.72, pp.5789-5796, 1998.

N. Thompson, S. Warner, R. J. Locarnini, and . Colonno, Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine, Antimicrob Agents Chemother, vol.48, pp.3498-3507, 2004.

P. Gibbs, B. Parvaz, C. Werle, F. Trepo, and . Zoulim, Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient, J Hepatol, vol.39, pp.1085-1089, 2003.

G. H. Wang and C. Seeger, The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis, Cell, vol.71, issue.4, pp.633-670, 1992.
DOI : 10.1016/0092-8674(92)90599-8

C. Westland, W. Th-delaney, H. Yang, S. S. Chen, P. Marcellin et al., Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1 1Gilead Sciences gratefully acknowledges the patients, investigators, and study site personnel who participated in clinical trials GS-98-437 and GS-98-438., Gastroenterology, vol.125, issue.1, pp.107-116, 2003.
DOI : 10.1016/S0016-5085(03)00700-5

X. Xiong, C. Flores, H. Yang, J. J. Toole, and C. S. Gibbs, Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovirin vitro, Hepatology, vol.34, issue.4, pp.1669-1673, 1998.
DOI : 10.1002/hep.510280629

F. Zoulim, Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection, Antiviral Research, vol.64, issue.1, pp.1-15, 2004.
DOI : 10.1016/S0166-3542(04)00162-7

URL : https://hal.archives-ouvertes.fr/inserm-00136413

. Cheng, 2', 3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo, Antimicrob Agents Chemother, vol.40, pp.448-453, 1996.

F. Zoulim and C. Seeger, Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase, J Virol, vol.68, pp.6-13, 1994.